(1)
Comparison of a Novel Tazarotene 0.045% Lotion to Tazarotene 0.1% Cream: Patient-Reported Outcomes from a Phase 2 Clinical Trial. J of Skin 2019, 3, S9. https://doi.org/10.25251/skin.3.supp.9.